Effect of liver regeneration on malignant hepatic tumors

World Journal of Gastroenterology

Volumn 20, Issue 43, 2014, Pages 16167-16177

  Shi, Ji Hua ^a   Line, Pål Dag ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Colorectal cancer; Epithelial to mesenchymal transition; Hepatic progenitor cell; Hepatocellular carcinoma; Liver regeneration; Recurrence

Indexed keywords

CANCER RECURRENCE; CANCER SURGERY; CLINICAL FEATURE; HEPATIC PROGENITOR CELL; HUMAN; LIVER CANCER; LIVER REGENERATION; LIVER SURGERY; METASTASIS; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TUMOR GROWTH; ADVERSE EFFECTS; ANIMAL; CANCER STEM CELL; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CELL PROLIFERATION; COLORECTAL TUMOR; LIVER NEOPLASMS; LIVER RESECTION; METABOLISM; MICROMETASTASIS; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; SECONDARY; SIGNAL TRANSDUCTION; TIME; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT; TUMOR RECURRENCE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CELL PROLIFERATION; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER REGENERATION; NEOPLASM MICROMETASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; RISK ASSESSMENT; RISK FACTORS; SIGNAL TRANSDUCTION; TIME FACTORS; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT;

EID: 84912558058     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i43.16167     Document Type: Review

References (121)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156 [PMID: 11668491 DOI: 10.1002/ijc.1440].
2. Edge S, Byrd D, Compton C, Fritz A, Greene F, Trotti III A. AJCC Cancer Staging Manual, 7th ed. American Joint Committee on Cancer. New York: Springer, 2009.
3. Gospodarowicz M, Wittekind C, Sobin L. TNM Classification of Malignant Tumours. Publisher: Wiley-Blackwell, 2009.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107].
5. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16 [PMID: 15508102 DOI: 10.1053/j.gastro.2004.09.011].
6. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524 [PMID: 11870363 DOI: 10.1053/jhep.2002.32089].
7. Wayne JD, Lauwers GY, Ikai I, Doherty DA, Belghiti J, Yamao-ka Y, Regimbeau JM, Nagorney DM, Do KA, Ellis LM, Curley SA, Pollock RE, Vauthey JN. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2002; 235: 722-730; discussion 730-731 [PMID: 11981219 DOI: 10.1097/00000658-200205000-00015].
8. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K, Yamasaki S. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28: 1241-1246 [PMID: 9794907 DOI: 10.1002/hep.510280511].
9. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917 [PMID: 14667750].
10. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43 [PMID: 19058754 DOI: 10.1016/S1470-2045(08)70284-5].
11. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434-1440 [PMID: 10573522 DOI: 10.1002/hep.510300629].
12. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790-799; discussion 799-800 [PMID: 10363892].
13. Mulcahy MF. Management of hepatocellular cancer. Curr Treat Options Oncol 2005; 6: 423-435 [PMID: 16107245 DOI: 10.1007/s11864-005-0045-7].
14. Seitz K. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma and liver metastases. Ultraschall Med 2005; 26: 267-269 [PMID: 16123919 DOI: 10.1055/s-2005-858559].
15. Yan FH. [Imaging diagnosis of hepatocellular carcinoma]. Zhonghua Yixue Zazhi 2005; 85: 297-299 [PMID: 15854501].
16. de Jong KP, Slooff MJ, de Vries EG, Brouwers MA, Terpstra OT. Effect of partial liver resection on tumour growth. J Hepatol 1996; 25: 109-121 [PMID: 8836910 DOI: 10.1016/S0168-8278(96)80336-9].
17. Lee WJ. [Imaging diagnosis of hepatocellular carcinoma]. Korean J Gastroenterol 2005; 45: 234-246 [PMID: 15843749].
18. Murakami T, Takamura M, Kim T, Hori M, Federle MP, Onishi H, Tomoda K, Nakamura H. Double phase CT during hepatic arteriography for diagnosis of hepatocellular carcinoma. Eur J Radiol 2005; 54: 246-252 [PMID: 15837405 DOI: 10.1016/j.ejrad.2004.05.013].
19. Paschos KA, Bird NC. Liver regeneration and its impact on post-hepatectomy metastatic tumour recurrence. Anticancer Res 2010; 30: 2161-2170 [PMID: 20651365].
20. Marín-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: Surgical indications and results. Crit Rev Oncol Hematol 2003; 47: 13-27 [PMID: 12853096 DOI: 10.1016/S1040-8428(02)00213-5].
21. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, Watanabe G, Tsurumaru M. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25 [PMID: 8380116].
22. Poon RT, Fan ST, O'Suilleabhain CB, Wong J. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 2002; 195: 311-318 [PMID: 12229937 DOI: 10.1016/S1072-7515(02)01226-7].
23. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238: 703-710 [PMID: 14578733 DOI: 10.1097/01.sla.0000094549.11754.e6].
24. Heinrich S, Jochum W, Graf R, Clavien PA. Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice. J Hepatol 2006; 45: 35-42 [PMID: 16698111 DOI: 10.1016/j.jhep.2006.02.020].
25. Shi JH, Huitfeldt HS, Suo ZH, Line PD. Growth of hepatocellular carcinoma in the regenerating liver. Liver Transpl 2011; 17: 866-874 [PMID: 21542129 DOI: 10.1002/lt.22325].
26. Yoon SS, Kim SH, Gonen M, Heffernan NM, Detwiller KY, Jarnagin WR, D'Angelica M, Blumgart LH, Tanabe KK, Dematteo RP. Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 2006; 13: 353-362 [PMID: 16474912 DOI: 10.1245/ASO.2006.03.060].
27. Harun N, Nikfarjam M, Muralidharan V, Christophi C. Liver regeneration stimulates tumor metastases. J Surg Res 2007; 138: 284-290 [PMID: 17254608 DOI: 10.1016/j.jss.2006.06.024].
28. Hoekstra LT, van Lienden KP, Verheij J, van der Loos CM, Heger M, van Gulik TM. Enhanced tumor growth after portal vein embolization in a rabbit tumor model. J Surg Res 2013; 180: 89-96 [PMID: 23149224 DOI: 10.1016/j.jss.2012.10.032].
29. Neeleman N, Andersson R. Repeated liver resection for recurrent liver cancer. Br J Surg 1996; 83: 893-901 [PMID: 8813771 DOI: 10.1002/bjs.1800830705].
30. Shimada M, Matsumata T, Taketomi A, Yamamoto K, Itasaka H, Sugimachi K. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 1994; 115: 703-706 [PMID: 8197562].
31. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999; 229: 216-222 [PMID: 10024103 DOI: 10.1097/00000 658-199902000-00009].
32. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T, Yukaya H. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-494 [PMID: 8392955].
33. Bismuth H, Samuel D, Engerran L. Treatment of unresectable hepatocellular carcinoma. N Engl J Med 1995; 333: 878 [PMID: 7544440 DOI: 10.1056/NEJM199509283331314].
34. Del Gaudio M, Ercolani G, Ravaioli M, Cescon M, Lauro A, Vivarelli M, Zanello M, Cucchetti A, Vetrone G, Tuci F. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant 2008; 8: 1177-1185 [DOI: 10.1111/j.1600-6143.2008.02229.x].
35. Chen PJ, Chen DS, Lai MY, Chang MH, Huang GT, Yang PM, Sheu JC, Lee SC, Hsu HC, Sung JL. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology 1989; 96: 527-529 [PMID: 2535996].
36. Yamamoto T, Kajino K, Kudo M, Sasaki Y, Arakawa Y, Hino O. Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. Hepatology 1999; 29: 1446-1452 [PMID: 10216128 DOI: 10.1002/hep.510290523].
37. Moolten FL, Bucher NL. Regeneration of rat liver: Transfer of humoral agent by cross circulation. Science 1967; 158: 272-274 [PMID: 6053886].
38. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699 [PMID: 8594428 DOI: 10.1056/NEJM199603143341104].
39. Wanless IR. Liver biopsy in the diagnosis of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 281-285, vii [PMID: 15831273 DOI: 10.1016/j.cld.2004.12.005].
40. Kassahun WT, Fangmann J, Harms J, Hauss J, Bartels M. Liver resection and transplantation in the management of hepatocellular carcinoma: A review. Exp Clin Transplant 2006; 4: 549-558 [PMID: 17238857].
41. Hagness M, Foss A, Line PD, Scholz T, Jørgensen PF, Fosby B, Boberg KM, Mathisen O, Gladhaug IP, Egge TS, Solberg S, Hausken J, Dueland S. Liver transplantation for nonresectable liver metastases from colorectal cancer. Ann Surg 2013; 257: 800-806 [PMID: 23360920 DOI: 10.1097/SLA.0b013e3182823957].
42. Frezza EE. Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses. Dig Dis Sci 2004; 49: 866-871 [PMID: 15259511].
43. Rhim H, Dodd GD. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999; 27: 221-229 [PMID: 10355885].
44. Scudamore CH, Lee SI, Patterson EJ, Buczkowski AK, July LV, Chung SW, Buckley AR, Ho SG, Owen DA. Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999; 177: 411-417 [PMID: 10365882 DOI: 10.1016/S0002-9610(99)00068-9].
45. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008; 359: 1995-2004 [PMID: 18923165 DOI: 10.1056/NEJMoa0804525].
46. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236 [PMID: 16250051 DOI: 10.1002/hep.20933].
47. Ellis LM, Chase J, Patt Y, Curley SA. Hepatic arterial infusion chemotherapy for colorectal cancer metastasis to the liver. Liver Cancer New York, NY: Springer, 1998: 150-172.
48. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213: 286-300 [PMID: 17559071 DOI: 10.1002/jcp.21172].
49. Taub R. Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-847 [PMID: 15459664 DOI: 10.1038/nrm1489].
50. Christophi C, Harun N, Fifis T. Liver regeneration and tumor stimulation- A review of cytokine and angiogenic factors. J Gastrointest Surg 2008; 12: 966-980 [PMID: 18181006 DOI: 10.1007/s11605-007-0459-6].
51. Jia C. Advances in the regulation of liver regeneration. Expert Rev Gastroenterol Hepatol 2011; 5: 105-121 [PMID: 21309676 DOI: 10.1586/egh.10.87].
52. Schoen Smith JM, Lautt WW. Nitric oxide and prostaglandins potentiate the liver regeneration cascade. Can J Gastroenterol 2006; 20: 329-334 [PMID: 16691298].
53. Kountouras J, Boura P, Lygidakis NJ. Liver regeneration after hepatectomy. Hepatogastroenterology 2001; 48: 556-562 [PMID: 11379353].
54. Mangnall D, Bird NC, Majeed AW. The molecular physiology of liver regeneration following partial hepatectomy. Liver Int 2003; 23: 124-138 [PMID: 12654135 DOI: 10.1034/j.1600-0676.2003.00812.x].
55. Kim TH, Mars WM, Stolz DB, Petersen BE, Michalopoulos GK. Extracellular matrix remodeling at the early stages of liver regeneration in the rat. Hepatology 1997; 26: 896-904 [PMID: 9328311 DOI: 10.1002/hep.510260415].
56. Wagenaar GT, Chamuleau RA, Pool CW, de Haan JG, Maas MA, Korfage HA, Lamers WH. Distribution and activity of glutamine synthase and carbamoylphosphate synthase upon enlargement of the liver lobule by repeated partial hepatectomies. J Hepatol 1993; 17: 397-407 [PMID: 8100248 DOI: 10.1016/S0168-8278(05)80224-7].
57. Umeda Y, Iwagaki H, Ozaki M, Ogino T, Iwamoto T, Yoshida R, Shinoura S, Matsuda H, Sadamori H, Tanaka N, Yagi T. Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis. Hepatogastroenterology 2009; 56: 971-977 [PMID: 19760923].
58. Cornellà H, Alsinet C, Villanueva A. Molecular pathogenesis of hepatocellular carcinoma. Alcohol Clin Exp Res 2011; 35: 821-825 [PMID: 21303380 DOI: 10.1111/j.1530-0277.2010.01406. x].
59. Kudo M. Hepatocellular carcinoma in 2011 and beyond: From the pathogenesis to molecular targeted therapy. Oncology 2011; 81 Suppl 1: 1-10 [PMID: 22212929 DOI: 10.1159/000333252].
60. Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010; 29: 4989-5005 [PMID: 20639898 DOI: 10.1038/onc.2010.236].
61. Nalesnik MA, Michalopoulos GK. Growth factor pathways in development and progression of hepatocellular carcinoma. Front Biosci (Schol Ed) 2012; 4: 1487-1515 [PMID: 22652888 DOI: 10.2741/S348].
62. Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya Y, Tsukada K, Saiki I. Increased surgical stress promotes tumor metastasis. Surgery 2003; 133: 547-555 [PMID: 12773983 DOI: 10.1067/msy.2003.141].
63. Man K, Ng KT, Lo CM, Ho JW, Sun BS, Sun CK, Lee TK, Poon RT, Fan ST. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases- Activation of cell invasion and migration pathways. Liver Transpl 2007; 13: 1669-1677 [PMID: 18044786 DOI: 10.1002/lt.21193].
64. Man K, Lo CM, Xiao JW, Ng KT, Sun BS, Ng IO, Cheng Q, Sun CK, Fan ST. The significance of acute phase small-forsize graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg 2008; 247: 1049-1057 [PMID: 18520234 DOI: 10.1097/SLA.0b013e31816ffab6XXX].
65. He G, Karin M. NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res 2011; 21: 159-168 [PMID: 21187858 DOI: 10.1038/cr.2010.183].
66. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364 [PMID: 8756718 DOI: 10.1016/S0092-8674(00)80108-7].
67. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, Steeg PS. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 1994; 54: 6504-6511 [PMID: 7527299].
68. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285 [PMID: 9008168 DOI: 10.1016/S0092-8674(00)81848-6].
69. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-746 [PMID: 14644200 DOI: 10.1016/j.ceb.2003.10.006].
70. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401 [PMID: 16572188 DOI: 10.1038/nrc1877].
71. Bird TG, Lorenzini S, Forbes SJ. Activation of stem cells in hepatic diseases. Cell Tissue Res 2008; 331: 283-300 [PMID: 18046579 DOI: 10.1007/s00441-007-0542-z].
72. Santoni-Rugiu E, Jelnes P, Thorgeirsson SS, Bisgaard HC. Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion. APMIS 2005; 113: 876-902 [PMID: 16480456 DOI: 10.1111/j.1600-0463.2005.apm-386.x].
73. Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003; 120: 117-130 [PMID: 12490302 DOI: 10.1016/S0925-4773(02)00338-6].
74. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45-S53 [PMID: 16447274 DOI: 10.1002/hep.20969].
75. Gaudio E, Carpino G, Cardinale V, Franchitto A, Onori P, Alvaro D. New insights into liver stem cells. Dig Liver Dis 2009; 41: 455-462 [PMID: 19403350].
76. Conzelmann LO, Hines IN, Kremer M, Perry AW, Lemasters JJ, Wheeler MD. Extrahepatic cells contribute to the progenitor/stem cell response following reduced-size liver transplantation in mice. Exp Biol Med (Maywood) 2007; 232: 571-580 [PMID: 17392494].
77. Sun Z, Zhang X, Locke JE, Zheng Q, Tachibana S, Diehl AM, Williams GM. Recruitment of host progenitor cells in rat liver transplants. Hepatology 2009; 49: 587-597 [PMID: 18972402 DOI: 10.1002/hep.22653].
78. Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy. Cell Tissue Res 2008; 331: 271-282 [PMID: 17901986 DOI: 10.1007/s00441-007-0483-6].
79. Zocco MA, Piscaglia AC, Giuliante F, Arena V, Novi M, Rinninella E, Tortora A, Rumi C, Nuzzo G, Vecchio FM, Bombardieri G, Gasbarrini A. CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease. Dig Liver Dis 2011; 43: 147-154 [PMID: 20688587 DOI: 10.1016/j.dld.2010.06.008].
80. Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta 2008; 1782: 61-74 [PMID: 18187050].
81. Lowes KN, Croager EJ, Olynyk JK, Abraham LJ, Yeoh GC. Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J Gastroenterol Hepatol 2003; 18: 4-12 [PMID: 12519217 DOI: 10.1046/j.1440-1746.2003.02906.x].
82. Sigal SH, Brill S, Fiorino AS, Reid LM. The liver as a stem cell and lineage system. Am J Physiol 1992; 263: G139-G148 [PMID: 1325126].
83. Gehling UM, Willems M, Dandri M, Petersen J, Berna M, Thill M, Wulf T, Müller L, Pollok JM, Schlagner K, Faltz C, Hossfeld DK, Rogiers X. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol 2005; 43: 845-853 [PMID: 16139387 DOI: 10.1016/j.jhep.2005.05.022].
84. Lemoli RM, Catani L, Talarico S, Loggi E, Gramenzi A, Baccarani U, Fogli M, Grazi GL, Aluigi M, Marzocchi G, Bernardi M, Pinna A, Bresadola F, Baccarani M, Andreone P. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells 2006; 24: 2817-2825 [PMID: 16931769 DOI: 10.1634/stemcells.2006-0333].
85. Langenberg MH, Nijkamp MW, Roodhart JM, Snoeren N, Tang T, Shaked Y, van Hillegersberg R, Witteveen PO, Vermaat JS, Kranenburg O, Kerbel RS, Medema RH, Borel Rinkes IH, Voest EE. Liver surgery induces an immediate mobilization of progenitor cells in liver cancer patients: A potential role for G-CSF. Cancer Biol Ther 2010; 9: 743-748 [PMID: 20215863 DOI: 10.4161/cbt.9.9.11551].
86. De Silvestro G, Vicarioto M, Donadel C, Menegazzo M, Marson P, Corsini A. Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery. Hepatogastroenterology 2004; 51: 805-810 [PMID: 15143921].
87. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006; 25: 3818-3822 [PMID: 16799623 DOI: 10.1038/sj.onc.1209558].
88. Fang CH, Gong JQ, Zhang W. Function of oval cells in hepatocellular carcinoma in rats. World J Gastroenterol 2004; 10: 2482-2487 [PMID: 15300889].
89. Dumble ML, Croager EJ, Yeoh GC, Quail EA. Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma. Carcinogenesis 2002; 23: 435-445 [PMID: 11895858 DOI: 10.1093/carcin/23.3.435].
90. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154: 537-541 [PMID: 10027411].
91. Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, Lesaffre E, Libbrecht L, Desmet V, Roskams T. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006; 49: 138-151 [PMID: 16879391 DOI: 10.1111/j.1365-2559.2006.02468.x].
92. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006; 12: 410-416 [PMID: 16532004 DOI: 10.1038/nm1377].
93. Theise ND, Yao JL, Harada K, Hytiroglou P, Portmann B, Thung SN, Tsui W, Ohta H, Nakanuma Y. Hepatic 'stem cell' malignancies in adults: Four cases. Histopathology 2003; 43: 263-271 [PMID: 12940779 DOI: 10.1046/j.1365-2559.2003.01707.x].
94. Yao Z, Mishra L. Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 2009; 8: 1691-1698 [PMID: 19901516].
95. Wang B, Jacob ST. Role of cancer stem cells in hepatocarcinogenesis. Genome Med 2011; 3: 11 [PMID: 21345246 DOI: 10.1186/gm225].
96. Yamashita T, Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest 2013; 123: 1911-1918 [PMID: 23635789 DOI: 10.1172/JCI66024].
97. Murakami T, Okada M, Hyodo T. CT versus MR imaging of hepatocellular carcinoma: Toward improved treatment decisions. Magnetic resonance in medical sciences. J Jpn Soci Magne Reson Med 2011; 11: 75-81 [DOI: 10.2463/mrms.11.75].
98. Guang Y, Xie L, Ding H, Cai A, Huang Y. Diagnosis value of focal liver lesions with SonoVue®-enhanced ultrasound compared with contrast-enhanced computed tomography and contrast-enhanced MRI: A meta- Analysis. J Cancer Res Clin Oncol 2011; 137: 1595-1605 [DOI: 10.1007/s00432-011-1035-8].
99. Peloso A, Franchi E, Canepa MC, Barbieri L, Briani L, Ferrario J, Bianco C, Quaretti P, Brugnatelli S, Dionigi P. Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer. HPB 2013; 15: 928-934 [DOI: 10.1111/hpb.12057].
100. Rampone B, Schiavone B, Martino A, Viviano C, Confuorto G. Current management strategy of hepatocellular carcinoma. World J Gastroenterol 2009; 15: 3210-3216 [PMID: 19598295].
101. Lee PH, Lin WJ, Tsang YM, Hu RH, Sheu JC, Lai MY, Hsu HC, May W, Lee CS. Clinical management of recurrent hepatocellular carcinoma. Ann Surg 1995; 222: 670-676 [PMID: 7487215].
102. Hargreaves GM, Adam R, Bismuth H. Results after nonsurgical local treatment of primary liver malignancies. Langenbecks Arch Surg 2000; 385: 185-193 [PMID: 10857489].
103. Farges O, Regimbeau JM, Belghiti J. Aggressive management of recurrence following surgical resection of hepatocellular carcinoma. Hepatogastroenterology 1998; 45 Suppl 3: 1275-1280 [PMID: 9730388].
104. Hu RH, Lee PH, Yu SC, Dai HC, Sheu JC, Lai MY, Hsu HC, Chen DS. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery 1996; 120: 23-29 [PMID: 8693418].
105. Shuto T, Kinoshita H, Hirohashi K, Kubo S, Tanaka H, Tsukamoto T, Okuda T. Indications for, and effectiveness of, a second hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 1996; 43: 932-937 [PMID: 8884316].
106. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, Perrin H, Azoulay D. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688-701; discussion 701-703 [PMID: 9409568].
107. Kinoshita S, Hirai R, Yamano T, Yuasa I, Tsukuda K, Shimizu N. Angiogenesis inhibitor TNP-470 can suppress hepatocellular carcinoma growth without retarding liver regeneration after partial hepatectomy. Surg Tod 2004; 34: 40-46.
108. Tanaka H, Taniguchi H, Mugitani T, Koishi Y, Masuyama M, Koyama H, Hoshima M, Takahashi T. Angiogenesis inhibitor TNP-470 prevents implanted liver metastases after partial hepatectomy in an experimental model without impairing wound healing. British J Surg 1996; 83: 1444-1447.
109. Drixler TA, Vogten MJ, Ritchie ED, vanVroonhoven TJ, Gebbink MF, Voest EE, Borel Rinkes IH. Liver regeneration is an angiogenesis- Associated phenomenon. Ann Surg 2002; 236: 703-711; discussion 711-712 [PMID: 12454508 DOI: 10.1097/01. SLA.0000036265.92985.5F].
110. Ronco MT, Francés D, de Luján Alvarez M, Quiroga A, Monti J, Parody JP, Pisani G, Carrillo MC, Carnovale CE. Vascular endothelial growth factor and nitric oxide in rat liver regeneration. Life Sci 2007; 81: 750-755 [PMID: 17706723].
111. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001; 49: 121-130 [PMID: 11118484].
112. Ager EI, Neo J, Christophi C. The renin- Angiotensin system and malignancy. Carcinogenesis 2008; 29: 1675-1684 [PMID: 18632755 DOI: 10.1093/carcin/bgn171].
113. Koh SL, Ager EI, Christophi C. Liver regeneration and tumour stimulation: Implications of the renin- Angiotensin system. Liver Int 2010; 30: 1414-1426.
114. Kroemer G, Galluzzi L, Zitvogel L. Immunological effects of chemotherapy in spontaneous breast cancers. Oncoimmunology 2013; 2: e27158 [PMID: 24498568 DOI: 10.4161/onci.27158].
115. Kono K, Mimura K, Kiessling R. Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation. Cell Death Dis 2013; 4: e688 [PMID: 23788045 DOI: 10.1038/cddis.2013.207].
116. Schmidt N, Neumann-Haefelin C, Thimme R. Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy. Dig Dis 2012; 30: 483-491 [PMID: 23108304 DOI: 10.1159/000341697].
117. Breous E, Thimme R. Potential of immunotherapy for hepatocellular carcinoma. J Hepatol 2011; 54: 830-834 [PMID: 21145836 DOI: 10.1016/j.jhep.2010.10.013].
118. Matar P, Alaniz L, Rozados V, Aquino JB, Malvicini M, Atorrasagasti C, Gidekel M, Silva M, Scharovsky OG, Mazzolini G. Immunotherapy for liver tumors: present status and future prospects. J Biomed Sci 2009; 16: 30 [PMID: 19272130 DOI: 10.1186/1423-0127-16-30].
119. Bremer C, Allkemper T, Menzel J, Sulkowski U, Rummeny E, Reimer P. Preliminary clinical experience with laserinduced interstitial thermotherapy in patients with hepatocellular carcinoma. J Mag Reson Imag 1998; 8: 235-239.
120. Vogl T, Mack M, Straub R, Eichler K, Engelmann K, Roggan A, Zangos S. Percutaneous interstitial thermotherapy of malignant liver tumors]. RöFo 2000; 172: 12.
121. Araújo TG, de Oliveira AG, Tobar N, Saad MJ, Moreira LR, Reis ER, Nicola EM, de Jorge GL, dosTártaro RR, Boin IF, Teixeira AR. Liver regeneration following partial hepatectomy is improved by enhancing the HGF/Met axis and Akt and Erk pathways after low-power laser irradiation in rats. Lasers Med Sci 2013; 28: 1511-1517 [PMID: 23334786 DOI: 10.1007/s10103-013-1264-y].